Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Acromegaly is a rare chronic disease due to excessive secretion of growth hormone (GH) and insulin-like growth factor-I (IGF-I), caused in over 98% of cases by GH-secreting pituitary adenoma. Prolonged exposure to GH/IGF-I excess is the cause of increased mortality and morbidity in these patients. Arthropathy occurs in about 75% of acromegalic patients. Any joint may be affected, with the development of osteoarthritis, arthralgia, and an increase in fracture risk. The aims of the present project are to evaluate the dimensions of hands and feet with the 3D scanner method and to perform a quantitative analysis of movement through Gait Analysis technique in de novo patients with acromegaly (group # 1) and in patients with different disease status (group #2).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• De novo patients with acromegaly (group # 1), diagnosed according to Endocrine Society guidelines,

• Age equal to18 years or older

• Acromegalic patients with different disease status (group #2)

• Age equal to18 years or older

Locations
Other Locations
Italy
Istituto Auxologico Italiano IRCCS San Luca
RECRUITING
Milan
Contact Information
Primary
Sara Farina, Doctor
sara.farina@unimi.it
+393386822298
Time Frame
Start Date: 2019-06-18
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 30
Treatments
Population # 1
De novo patients with acromegaly, diagnosed according to Endocrine Society guidelines, aged equal or above 18 years old
Population # 2
Acromegalic patients with different disease status (active disease despite ongoing therapies, controlled disease under medical therapy, and disease remission), aged equal or above 18 years old
Sponsors
Leads: Istituto Auxologico Italiano
Collaborators: Politecnico di Milano

This content was sourced from clinicaltrials.gov

Similar Clinical Trials